ARCHIVES

NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done

This article is from The Cancer Letter archive.

Vol. 10 No. 03 | January 20, 1984

Download PDF Visit The Full Archive

Related Articles

Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations

August 31, 2001

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008

In Brief: Fred Hutchinson Center celebrates Massive Move Of 36 Labs, 400 Employees to New Campus

June 25, 1993

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012